Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease
Read More
Tag: cancer research
Vortex expands research at London Cancer Hub’s Innovation Gateway
The Cancer Hub aims to create a world-leading ecosystem for cancer research
Read More
Cancer Research UK invests £123m in Scotland
The investment will support research into cancer treatments and diagnosis
Read More
UKRI’s MRC invests £2m for hard-to-treat cancers
Four research innovation teams are set to receive £500,000 each
Read More
Cancer Research UK reach agreement with UCB
The partnership will concentrate on the development of two investigational antibodies
Read More
canSERV rolls out cancer research services across Europe
European wide research infrastructures, oncology experts and patient associations link up to combat cancer
Read More
Cancer research in the UK faces ‘perfect storm’ of funding cuts
Experts have raised ‘serious concerns’ over government plans for UK science funding
Read More
CR UK makes further cuts in COVID’s wake
The charity is slashing £45 million from its research budget
Read More
First convergent science centre launched in UK
Scientists are “re-imagining ultrasound technology to develop a treatment that can liquefy cancer cells in the body using microscopic bubbles”.
Read More
ICR launches ‘Darwinian’ cancer drug programme
The programme is to be launched in a £75 million state-of-the-art global centre of expertise in anti-evolution therapies in London.
Read More
Women with breast cancer risk opting out of tamoxifen therapy
The majority of women at high risk of developing breast cancer decide against prophylactic treatment with tamoxifen, suggest findings of a new study funded by Cancer Research UK and published in Breast Cancer Research and Treatment.
Read More
Bicycle, CR UK launch first trial of a bicyclic peptide
Bicycle Therapeutics and Cancer Research UK have initiated the first clinical study to assess a bicyclic peptide, evaluating its potential in patients with advanced solid tumours.
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
